Cited by 52Bariatric Surgery and OutcomesDiabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

How much weight loss is required for cardiovascular benefits? Insights from a metabolic surgery matched-cohort study

Aminian, Ali, Zajichek, Alexander, Tu, Chao, Wolski, Kathy E., Brethauer, Stacy A., Schauer, Philip R., Kattan, Michael W., Nissen, Steven E.·2020·Annals of Surgery

Abstract

OBJECTIVE: The aim of this study was to determine the minimum amount of weight loss required to see a reduction in major adverse cardiovascular events (MACE). BACKGROUND: Although obesity is an established risk factor for morbidity and mortality, the minimum amount of weight loss to have a meaningful impact on cardiovascular health and survival is unknown. METHODS: Patients with obesity (body mass index ≥30 kg/m) and type 2 diabetes who underwent metabolic surgery in an academic center (1998-2017) were propensity-matched 1:5 to nonsurgical patients who received usual care. The adjusted linear and nonlinear effects of weight loss (achieved in the first 18 months after the index date) were studied to identify cut-offs for the minimum weight loss to achieve decreased risk of all-cause mortality and MACE (composite of all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation). RESULTS: A total of 7201 patients (1223 surgical and 5978 nonsurgical) with a median follow-up time of 4.9 years (interquartile range, 3.5-7) were included. The positive effect of metabolic surgery was still present after adjusting for weight loss amounts, suggesting that there are weight loss-independent factors contributing to a reduction in risk of MACE and all-cause mortality in the surgical cohort. After considering the weighted estimates from a diverse set of models, the risk of MACE decreases after approximately 10% of weight is lost in the surgical group and approximately 20% in the nonsurgical group. For all-cause mortality, the threshold for benefit appeared to be approximately 5% weight loss after metabolic surgery and 20% in the nonsurgical group. CONCLUSIONS: This large matched-cohort study identified the minimum weight loss thresholds for reduction in risk of MACE and all-cause mortality in patients with obesity and diabetes. Furthermore, in our analysis, the effect of surgery was still present after accounting for weight loss, which may suggest the presence of weight-independent beneficial effects of metabolic surgery on MACE and survival.

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000004369

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bariatric surgery results in very substantial weight loss, but ancillary effects such as incretin response and changes of the gut microbiome have also been described, and some refer to bariatric surgery as metabolic surgery.

    “Clearly, bariatric surgery results in very substantial weight loss, but ancillary effects also have been described, such as incretin response and changes of the gut microbiome, and some refer to bariatric surgery as metabolic surgery.17”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aminian, A., Zajichek, A., Tu, C., Wolski, K. E., Brethauer, S. A., Schauer, P. R., Kattan, M. W., & Nissen, S. E.
Affiliations
  • Cleveland Clinic (US)
  • The Ohio State University Wexner Medical Center (US)
  • Pennington Biomedical Research Center (US)
Corresponding author
Aminian, Ali
Venue
Annals of Surgery
Published
2020-10
Volume
272
Issue
4
Pages
639-645
ISSN
  • 0003-4932 (ISSN-L)
  • 1528-1140
OpenAlex
W3085618048
Cited by
52
References
25
Citations by year
2026: 5 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 14 · 2021: 6 · 2020: 1
FWCI
6.85
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Surgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
metabolic surgery, weight loss, obesity, type 2 diabetes, major adverse cardiovascular events, all-cause mortality, bariatric surgery, cardiovascular risk reduction
MeSH terms
Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Obesity, Cohort Studies, Weight Loss, Diabetes Complications, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review